PATIENTS TAKING part in early tests of a Russian vaccine developed antibodies with “no serious adverse events”, the Lancet medical journal has reported, quoting findings by several Russian scientists.
But researchers said longer and larger trials were needed to prove the Sputnik V vaccine would be safe and effective.
Last month, Russia announced that the vaccine had been approved by the country’s health regulatory body – a move that was met with scepticism in some countries.
A number of experts, particularly in the West, warned Moscow was moving too quickly, skipping a key stage required for research.
President Vladimir Putin has said that one of his two daughters has already been vaccinated.
And of Friday, Defence Minister Sergei Shoigu was shown on Russia’s state TV getting the jab himself. BBC